Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CARM1 | Q86X55 | 5/20 | 1.00 |
| ▸ | AMD1 | P17707 | 4/20 | 1.00 |
| ▸ | PCMT1 | P22061 | 3/20 | 0.87 |
| ▸ | PRMT5 | O14744 | 3/20 | 0.87 |
| ▸ | PRMT1 | Q99873 | 3/20 | 0.87 |
| ▸ | NSD3 | Q9BZ95 | 2/20 | 0.87 |
| ▸ | PRMT3 | O60678 | 2/20 | 0.87 |
| ▸ | PNMT | P11086 | 2/20 | 0.87 |
| ▸ | PRMT6 | Q96LA8 | 2/20 | 0.87 |
| ▸ | WDR77 | Q9BQA1 | 2/20 | 0.87 |
| ▸ | PRMT7 | Q9NVM4 | 2/20 | 0.87 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.87 |
| ▸ | KDR | P35968 | 1/20 | 0.87 |
| ▸ | PRMT8 | Q9NR22 | 1/20 | 0.87 |
| ▸ | NNMT | P40261 | 3/20 | 0.72 |
| ▸ | DOT1L | Q8TEK3 | 5/20 | 0.71 |
| ▸ | NSD2 | O96028 | 3/20 | 0.71 |
| ▸ | SETD7 | Q8WTS6 | 3/20 | 0.71 |
| ▸ | EHMT2 | Q96KQ7 | 3/20 | 0.71 |
| ▸ | TRDMT1 | O14717 | 2/20 | 0.71 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ademetionine SCHEMBL13033865 | 1.00 | CARM1 (1.00) | CARM1AMD1PCMT1PRMT5PRMT1 | |
| Ademetionine SCHEMBL600368 | 1.00 | CARM1 (1.00) | CARM1AMD1PCMT1PRMT5PRMT1 | |
| Ademetionine SCHEMBL66767 | 1.00 | CARM1 (1.00) | CARM1AMD1PCMT1PRMT5PRMT1 | |
| Ademetionine SCHEMBL2007787 | 1.00 | CARM1 (1.00) | CARM1AMD1PCMT1PRMT5PRMT1 | |
| Ademetionine SCHEMBL599664 | 1.00 | CARM1 (1.00) | CARM1AMD1PCMT1PRMT5PRMT1 | |
| Ademetionine SCHEMBL4164615 | 1.00 | CARM1 (1.00) | CARM1AMD1PCMT1PRMT5PRMT1 | |
| Ademetionine SCHEMBL55479 | 1.00 | CARM1 (1.00) | CARM1AMD1PCMT1PRMT5PRMT1 | |
| Ademetionine SCHEMBL59293 | 1.00 | CARM1 (1.00) | CARM1AMD1PCMT1PRMT5PRMT1 | |
| Ademetionine SCHEMBL3202538 | 1.00 | CARM1 (1.00) | CARM1AMD1PCMT1PRMT5PRMT1 | |
| Ademetionine SCHEMBL9518716 | 1.00 | CARM1 (1.00) | CARM1AMD1PCMT1PRMT5PRMT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220153875-A1 | ANTIGEN-BINDING MOLECULE CONTAINING ANTIGEN-BINDING DOMAIN OF WHICH BINDING ACTIVITY TO ANTIGEN IS CHANGED DEPENDING ON MTA, AND LIBRARY FOR OBTAINING SAID ANTIGEN-BINDING DOMAIN | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2022-05-19 | — | — | US | disclosed |
| US-20100150871-A1 | Genetically-modified strain of yeast with an increased production and output of s-adenosylmethionine (sam) | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQE (FR) | 2010-06-17 | — | — | US | disclosed |
| US-20090197824-A1 | Extended Release Pharmaceutical Formulations of S-Adenosylmethionine | METHYLATION SCIENCES INTERNATIONAL SRL (BB) | 2009-08-06 | — | — | US | disclosed |
| US-20090088404-A1 | Extended Release Pharmaceutical Formulations of S-Adenosylmethionine | METHYLATION SCIENCES INTERNATIONAL SRL (BB) | 2009-04-02 | — | — | US | disclosed |
| US-20080206333-A1 | Extended Release Pharmaceutical Formulations of S-Adenosylmethionine | METHYLATION SCIENCES INTERNATIONAL SRL (BB) | 2008-08-28 | — | — | US | disclosed |
| US-20080132525-A1 | isoforms DNMT1 and DNMT3b2; for example: 2-amino-4-(((2S,3S,4R,5R)-3,4-dihydroxy-5-(6-(phenethylamino)-9H-purin-9-yl)-tetrahydrofuran-2-yl)methylthio)butanoic acid | METHYLGENE INC. (CA) | 2008-06-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220153875-A1 | ANTIGEN-BINDING MOLECULE CONTAINING ANTIGEN-BINDING DOMAIN OF WHICH BINDING ACTIVITY TO ANTIGEN IS CHANGED DEPENDING ON MTA, AND LIBRARY FOR OBTAINING SAID ANTIGEN-BINDING DOMAIN | MICA, TNFSF10, HLA-A | CARM1 839/4885AMD1 322/4885PCMT1 655/4885 |
| US-20100150871-A1 | Genetically-modified strain of yeast with an increased production and output of s-adenosylmethionine (sam) | AHCY, MAT2A, MAT1A | CARM1 220/4885AMD1 4/4885PCMT1 647/4885 |
| US-20080206333-A1 | Extended Release Pharmaceutical Formulations of S-Adenosylmethionine | MAT2A, MAT1A, AMD1 | CARM1 287/4885AMD1 3/4885PCMT1 340/4885 |
| US-20090197824-A1 | Extended Release Pharmaceutical Formulations of S-Adenosylmethionine | MAT2A, MAT1A, AMD1 | CARM1 287/4885AMD1 3/4885PCMT1 340/4885 |
| US-20080132525-A1 | isoforms DNMT1 and DNMT3b2; for example: 2-amino-4-(((2S,3S,4R,5R)-3,4-dihydroxy-5-(6-(phenethylamino)-9H-purin-9-yl)-tetrahydrofuran-2-yl)methylthio)butanoic acid | DNMT3B, DNMT1, DNMT3L | CARM1 158/4885AMD1 122/4885PCMT1 872/4885 |
| US-20090088404-A1 | Extended Release Pharmaceutical Formulations of S-Adenosylmethionine | MAT2A, MAT1A, AMD1 | CARM1 287/4885AMD1 3/4885PCMT1 340/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.